Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 7.
Article
Atti, Ana;
Insalata, Ferdinando;
Carr, Edward J;
Otter, Ashley D;
Foulkes, Sarah;
Wu, Mary Y;
Crick COVID Immunity Pipeline, .;
... SIREN Study Group, .; + view all
(2023)
Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.
Journal of Infection
10.1016/j.jinf.2023.07.007.
(In press).
|
|
Carr, Edward J;
Wu, Mary Y;
Gahir, Joshua;
Harvey, Ruth;
Townsley, Hermaleigh;
Bailey, Chris;
Fowler, Ashley S;
... Crick COVID Serology Consortium, Consortium; + view all
(2023)
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.
The Lancet Infectious Diseases
10.1016/S1473-3099(23)00289-X.
(In press).
|
 |
|
Dowgier, G;
Hobbs, A;
Greenwood, D;
Shawe-Taylor, M;
Stevenson-Leggett, P;
Bazire, J;
Penn, R;
... Wu, MY; + view all
(2025)
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
Vaccine
, 54
, Article 126960. 10.1016/j.vaccine.2025.126960.
|
|
|
Neale, Isabel;
Ali, Mohammad;
Kronsteiner, Barbara;
Longet, Stephanie;
Abraham, Priyanka;
Deeks, Alexandra S;
Brown, Anthony;
... PITCH Consortium; + view all
(2023)
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.
mBio
, Article e0121223. 10.1128/mbio.01212-23.
|
|
Shawe-Taylor, Marianne;
Greenwood, David;
Hobbs, Agnieszka;
Dowgier, Giulia;
Penn, Rebecca;
Sanderson, Theo;
Stevenson-Leggett, Phoebe;
... Wall, Emma C; + view all
(2024)
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
The Lancet
, 403
(10432)
pp. 1133-1136.
10.1016/S0140-6736(24)00316-7.
|
|
Townsley, Hermaleigh;
Gahir, Joshua;
Russell, Timothy W;
Greenwood, David;
Carr, Edward J;
Dyke, Matala;
Adams, Lorin;
... Wall, Emma C; + view all
(2024)
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
PLOS ONE
, 19
(3)
, Article e0294897. 10.1371/journal.pone.0294897.
|
|
Upasani, Vinit;
Townsend, Katie;
Wu, Mary Y;
Carr, Edward J;
Hobbs, Agnieszka;
Dowgier, Giulia;
Ragno, Martina;
... Lowe, David M; + view all
(2023)
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Clinical Infectious Diseases
, Article ciad368. 10.1093/cid/ciad368.
(In press).
|
